Microdomains, Inflammation, and Atherosclerosis

Circulation Research

Volumn 118, Issue 4, 2016, Pages 679-691

  Sorci Thomas, Mary G ^a,b   Thomas, Michael J ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

apolipoprotein A I; atherosclerosis; cholesterol; inflammation; membrane microdomains

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; FAT DROPLET; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ABC TRANSPORTER A1; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; FEEDBACK SYSTEM; FOAM CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPID RAFT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ARTERY; ESTERIFICATION; HYDROLYSIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAIN; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTERIFICATION; FOAM CELLS; HUMANS; HYDROLYSIS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; T-LYMPHOCYTES;

EID: 84959058398     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306246     Document Type: Article

References (156)

1. Goldstein JL, Brown MS., A century of cholesterol and coronaries: from plaques to genes to statins. Cell 2015 161 161 172. doi: 10.1016/j.cell.2015.01.036.
2. Horton JD, Cohen JC, Hobbs HH., Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 2007 32 71 77. doi: 10.1016/j.tibs.2006.12.008.
3. Drew BG, Hamidi H, Zhou Z, Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression. J Biol Chem 2015 290 5566 5581. doi: 10.1074/jbc.M114.606459.
4. Steinberg D., Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002 8 1211 1217. doi: 10.1038/nm1102-1211.
5. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK., Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986 6 131 138
6. Libby P, Ridker PM, Maseri A., Inflammation and atherosclerosis. Circulation 2002 105 1135 1143
7. Pittman RC, Steinberg D., Sites and mechanisms of uptake and degradation of high density and low density lipoproteins. J Lipid Res 1984 25 1577 1585
8. Kingwell BA, Chapman MJ, Kontush A, Miller NE., HDL-targeted therapies: progress, failures and future. Nat Rev Drug Discov 2014 13 445 464. doi: 10.1038/nrd4279.
9. Rosenson RS, Brewer HB Jr, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR., Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 2016 13 48 60. doi: 10.1038/nrcardio.2015.124.
10. Rader DJ, Hovingh GK., HDL and cardiovascular disease. Lancet 2014 384 618 625. doi: 10.1016/S0140-6736(14)61217-4.
11. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M., Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996 271 518 520
12. Morton RE, Zilversmit DB., The separation of apolipoprotein D from cholesteryl ester transfer protein. Biochim Biophys Acta 1981 663 350 355
13. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF., The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999 104 R25 R31. doi: 10.1172/JCI8119.
14. Fielding CJ, Fielding PE., Molecular physiology of reverse cholesterol transport. J Lipid Res 1995 36 211 228
15. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N., HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008 7 365 375. doi: 10.1016/j.cmet.2008.03.001.
16. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ., Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011 364 127 135. doi: 10.1056/NEJMoa1001689.
17. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW., HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 2014 371 2383 2393. doi: 10.1056/NEJMoa1409065.
18. Sorci-Thomas MG, Thomas MJ., High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arterioscler Thromb Vasc Biol 2012 32 2561 2565. doi: 10.1161/ATVBAHA.112.300135.
19. Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR., Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. Biochim Biophys Acta 2012 1821 513 521. doi: 10.1016/j.bbalip.2011.08.003.
20. Tall AR, Yvan-Charvet L., Cholesterol, inflammation and innate immunity. Nat Rev Immunol 2015 15 104 116. doi: 10.1038/nri3793.
21. Mallat Z., Macrophages. Arterioscler Thromb Vasc Biol 2014 34 2509 2519. doi: 10.1161/ATVBAHA.114.304794.
22. Canton J, Neculai D, Grinstein S., Scavenger receptors in homeostasis and immunity. Nat Rev Immunol 2013 13 621 634. doi: 10.1038/nri3515.
23. Zabalawi M, Bharadwaj M, Horton H, Cline M, Willingham M, Thomas MJ, Sorci-Thomas MG., Inflammation and skin cholesterol in LDLr-/-, apoA-I-/-mice: link between cholesterol homeostasis and self-tolerance? J Lipid Res 2007 48 52 65. doi: 10.1194/jlr.M600370-JLR200.
24. Kruth HS., Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr Opin Lipidol 2011 22 386 393. doi: 10.1097/MOL.0b013e32834adadb.
25. Moore KJ, Sheedy FJ, Fisher EA., Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013 13 709 721. doi: 10.1038/nri3520.
26. Wüstner D, Mondal M, Tabas I, Maxfield FR., Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic 2005 6 396 412. doi: 10.1111/j.1600-0854.2005.00285.x.
27. Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, Gratton E, Parks J, Tontonoz P., Lxrs link metabolism to inflammation through abca1-dependent regulation of membrane composition and tlr signaling. Elife 2015 4 e08009. doi: 10.7554/eLife.08009.
28. Davidson WS, Gillotte KL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC., The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem 1995 270 5882 5890
29. Tabas I., Free cholesterol-induced cytotoxicity a possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med 1997 7 256 263. doi: 10.1016/S1050-1738(97)00086-8.
30. Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L., Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 2012 125 1905 1919. doi: 10.1161/CIRCULATIONAHA.111.066589.
31. Duewell P, Kono H, Rayner KJ, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010 464 1357 1361. doi: 10.1038/nature08938.
32. Choi AM, Nakahira K., Dampening insulin signaling by an NLRP3 'meta-flammasome'. Nat Immunol 2011 12 379 380. doi: 10.1038/ni.2028.
33. Menu P, Vince JE., The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011 166 1 15. doi: 10.1111/j.1365-2249.2011.04440.x.
34. Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L, Tschopp J., Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis 2011 2 e137. doi: 10.1038/cddis.2011.18.
35. Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP., CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci 2000 902 128 131
36. +-ATPase-Lyn complex in macrophages that promotes atherosclerosis. Sci Signal 2015 8 ra91. doi: 10.1126/scisignal.aaa9623.
37. Spann NJ, Garmire LX, McDonald JG, Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012 151 138 152. doi: 10.1016/j.cell.2012.06.054.
38. Moore KJ, Freeman MW., Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006 26 1702 1711. doi: 10.1161/01.ATV.0000229218.97976.43.
39. Williams KJ, Tabas I., The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995 15 551 561
40. Randolph GJ., Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res 2014 114 1757 1771. doi: 10.1161/CIRCRESAHA.114.301174.
41. Dubland JA, Francis GA., Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism. Front Cell Dev Biol 2015 3 3. doi: 10.3389/fcell.2015.00003.
42. Maxfield FR, Tabas I., Role of cholesterol and lipid organization in disease. Nature 2005 438 612 621. doi: 10.1038/nature04399.
43. den Hartigh LJ, Altman R, Norman JE, Rutledge JC., Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB. Am J Physiol Heart Circ Physiol 2014 306 H109 H120. doi: 10.1152/ajpheart.00137.2013.
44. Varela LM, Ortega A, Bermudez B, Lopez S, Pacheco YM, Villar J, Abia R, Muriana FJ., A high-fat meal promotes lipid-load and apolipoprotein B-48 receptor transcriptional activity in circulating monocytes. Am J Clin Nutr 2011 93 918 925. doi: 10.3945/ajcn.110.007765.
45. den Hartigh LJ, Connolly-Rohrbach JE, Fore S, Huser TR, Rutledge JC., Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes. J Immunol 2010 184 3927 3936. doi: 10.4049/jimmunol.0903475.
46. Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H., Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2015 35 1787 1797. doi: 10.1161/ATVBAHA.115.305609.
47. Tabas I., Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002 110 905 911. doi: 10.1172/JCI16452.
48. Anchisi L, Dessì S, Pani A, Mandas A., Cholesterol homeostasis: a key to prevent or slow down neurodegeneration. Front Physiol 2012 3 486. doi: 10.3389/fphys.2012.00486.
49. Hannaoui S, Shim SY, Cheng YC, Corda E, Gilch S., Cholesterol balance in prion diseases and Alzheimer's disease. Viruses 2014 6 4505 4535. doi: 10.3390/v6114505.
50. Shibuya Y, Chang CC, Huang LH, Bryleva EY, Chang TY., Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance. J Neurosci 2014 34 14484 14501. doi: 10.1523/JNEUROSCI.2567-14.2014.
51. Huttunen HJ, Kovacs DM., ACAT as a drug target for Alzheimer's disease. Neurodegener Dis 2008 5 212 214. doi: 10.1159/000113705.
52. Murphy SR, Chang CC, Dogbevia G, Bryleva EY, Bowen Z, Hasan MT, Chang TY., Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease. Mol Ther 2013 21 1497 1506. doi: 10.1038/mt.2013.118.
53. Brasaemle DL., Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007 48 2547 2559. doi: 10.1194/jlr.R700014-JLR200.
54. Paul A, Chang BH, Li L, Yechoor VK, Chan L., Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Circ Res 2008 102 1492 1501. doi: 10.1161/CIRCRESAHA.107.168070.
55. Ouimet M, Marcel YL., Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012 32 575 581. doi: 10.1161/ATVBAHA.111.240705.
56. Jo Y, Hartman IZ, DeBose-Boyd RA., Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet-associated endoplasmic reticulum membranes. Mol Biol Cell 2013 24 169 183. doi: 10.1091/mbc.E12-07-0564.
57. Bozza PT, Magalhães KG, Weller PF., Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim Biophys Acta 2009 1791 540 551. doi: 10.1016/j.bbalip.2009.01.005.
58. Melo RC, D'Avila H, Wan HC, Bozza PT, Dvorak AM, Weller PF., Lipid bodies in inflammatory cells: structure, function, and current imaging techniques. J Histochem Cytochem 2011 59 540 556. doi: 10.1369/0022155411404073.
59. Melo RC, Weller PF., Unraveling the complexity of lipid body organelles in human eosinophils. J Leukoc Biol 2014 96 703 712. doi: 10.1189/jlb.3RU0214-110R.
60. Orsini F, Cremona A, Arosio P, Corsetto PA, Montorfano G, Lascialfari A, Rizzo AM., Atomic force microscopy imaging of lipid rafts of human breast cancer cells. Biochim Biophys Acta 2012 1818 2943 2949. doi: 10.1016/j.bbamem.2012.07.024.
61. Shaw AS., Lipid rafts: now you see them, now you don't. Nat Immunol 2006 7 1139 1142. doi: 10.1038/ni1405.
62. Pike LJ., Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 2006 47 1597 1598. doi: 10.1194/jlr.E600002-JLR200.
63. Simons K, Ikonen E., Functional rafts in cell membranes. Nature 1997 387 569 572. doi: 10.1038/42408.
64. Anderson RG., The caveolae membrane system. Annu Rev Biochem 1998 67 199 225. doi: 10.1146/annurev.biochem.67.1.199.
65. Brown DA, London E., Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998 14 111 136. doi: 10.1146/annurev.cellbio.14.1.111.
66. Fielding CJ, Fielding PE., Membrane cholesterol and the regulation of signal transduction. Biochem Soc Trans 2004 32 65 69. doi: 10.1042/.
67. Chetty PS, Mayne L, Lund-Katz S, Stranz D, Englander SW, Phillips MC., Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry. Proc Natl Acad Sci USA 2009 106 19005 19010. doi: 10.1073/pnas.0909708106.
68. Martinez-Outschoorn UE, Sotgia F, Lisanti MP., Caveolae and signalling in cancer. Nat Rev Cancer 2015 15 225 237. doi: 10.1038/nrc3915.
69. Le Lay S, Hajduch E, Lindsay MR, Le Lièpvre X, Thiele C, Ferré P, Parton RG, Kurzchalia T, Simons K, Dugail I., Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Traffic 2006 7 549 561. doi: 10.1111/j.1600-0854.2006.00406.x.
70. Parton RG, Simons K., The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007 8 185 194. doi: 10.1038/nrm2122.
71. Dinic J, Riehl A, Adler J, Parmryd I., The T cell receptor resides in ordered plasma membrane nanodomains that aggregate upon patching of the receptor. Sci Rep 2015 5 10082. doi: 10.1038/srep10082.
72. Russell MR, Nickerson DP, Odorizzi G., Molecular mechanisms of late endosome morphology, identity and sorting. Curr Opin Cell Biol 2006 18 422 428. doi: 10.1016/j.ceb.2006.06.002.
73. Surls J, Nazarov-Stoica C, Kehl M, Olsen C, Casares S, Brumeanu TD., Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response. PLoS One 2012 7 e38733. doi: 10.1371/journal.pone.0038733.
74. Shirao S, Yoneda H, Shinoyama M, Sugimoto K, Koizumi H, Ishihara H, Oka F, Sadahiro H, Nomura S, Fujii M, Tamechika M, Kagawa Y, Owada Y, Suzuki M., A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts. J Cereb Blood Flow Metab 2015 35 835 842. doi: 10.1038/jcbfm.2014.260.
75. Ratajczak MZ., A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia 2015 29 776 782. doi: 10.1038/leu.2014.346.
76. Ratajczak MZ, Adamiak M., Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking. Leukemia 2015 29 1452 1457. doi: 10.1038/leu.2015.66.
77. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, Brewer HB Jr., Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 2001 280 818 823. doi: 10.1006/bbrc.2000.4219.
78. Curtiss LK, Valenta DT, Hime NJ, Rye KA., What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006 26 12 19. doi: 10.1161/01.ATV.0000194291.94269.5a.
79. Gao M, Zhao D, Schouteden S, Sorci-Thomas MG, Van Veldhoven PP, Eggermont K, Liu G, Verfaillie CM, Feng Y., Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression. Arterioscler Thromb Vasc Biol 2014 34 1900 1909. doi: 10.1161/ATVBAHA.114.304006.
80. Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ., Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J Lipid Res 2012 53 1890 1909. doi: 10.1194/jlr.M026674.
81. Sorci-Thomas MG, Pollard RD, Thomas MJ., What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport? Curr Opin Lipidol 2015 26 420 425. doi: 10.1097/MOL.0000000000000211.
82. Pollard RD, Blesso CN, Zabalawi M, Fulp B, Gerelus M, Zhu X, Lyons EW, Nuradin N, Francone OL, Li XA, Sahoo D, Thomas MJ, Sorci-Thomas MG., Procollagen C-endopeptidase enhancer protein 2 (PCPE2) reduces atherosclerosis in mice by enhancing scavenger receptor class B1 (SR-BI)-mediated high-density lipoprotein (HDL)-cholesteryl ester uptake. J Biol Chem 2015 290 15496 15511. doi: 10.1074/jbc.M115.646240.
83. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA., Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982 23 1206 1223
84. Tarling EJ, Edwards PA., ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter. Proc Natl Acad Sci USA 2011 108 19719 19724. doi: 10.1073/pnas.1113021108.
85. Tarling EJ, de Aguiar Vallim TQ, Edwards PA., Role of ABC transporters in lipid transport and human disease. Trends Endocrinol Metab 2013 24 342 350. doi: 10.1016/j.tem.2013.01.006.
86. Pagler TA, Wang M, Mondal M, Murphy AJ, Westerterp M, Moore KJ, Maxfield FR, Tall AR., Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling. Circ Res 2011 108 194 200. doi: 10.1161/CIRCRESAHA.110.228619.
87. Pollard RD, Fulp B, Samuel MP, Sorci-Thomas MG, Thomas MJ., The conformation of lipid-free human apolipoprotein A-I in solution. Biochemistry 2013 52 9470 9481. doi: 10.1021/bi401080k.
88. Bhat S, Sorci-Thomas MG, Tuladhar R, Samuel MP, Thomas MJ., Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes. Biochemistry 2007 46 7811 7821. doi: 10.1021/bi700384t.
89. Thomas MJ, Bhat S, Sorci-Thomas MG., Three-dimensional models of HDL apoA-I: implications for its assembly and function. J Lipid Res 2008 49 1875 1883. doi: 10.1194/jlr.R800010-JLR200.
90. Segrest JP, Jones MK, Catte A, Manchekar M, Datta G, Zhang L, Zhang R, Li L, Patterson JC, Palgunachari MN, Oram JF, Ren G., Surface density-induced pleating of a lipid monolayer drives nascent high-density lipoprotein assembly. Structure 2015 23 1214 1226. doi: 10.1016/j.str.2015.05.010.
91. Williams DL, Dawson PA, Newman TC, Rudel LL., Synthesis of apolipoprotein E by peripheral tissues. Potential functions in reverse cholesterol transport and cellular cholesterol metabolism. Ann N Y Acad Sci 1985 454 222 229
92. Foks AC, Lichtman AH, Kuiper J., Treating atherosclerosis with regulatory T cells. Arterioscler Thromb Vasc Biol 2015 35 280 287. doi: 10.1161/ATVBAHA.114.303568.
93. Subramanian M, Thorp E, Hansson GK, Tabas I., Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest 2013 123 179 188. doi: 10.1172/JCI64617.
94. Ait-Oufella H, Sage AP, Mallat Z, Tedgui A., Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 2014 114 1640 1660. doi: 10.1161/CIRCRESAHA.114.302761.
95. Dixon AM, Drake L, Hughes KT, Sargent E, Hunt D, Harton JA, Drake JR., Differential transmembrane domain GXXXG motif pairing impacts major histocompatibility complex (MHC) class II structure. J Biol Chem 2014 289 11695 11703. doi: 10.1074/jbc.M113.516997.
96. Anderson HA, Roche PA., MHC class II association with lipid rafts on the antigen presenting cell surface. Biochim Biophys Acta 2015 1853 775 780. doi: 10.1016/j.bbamcr.2014.09.019.
97. Jelinek D, Patrick SM, Kitt KN, Chan T, Francis GA, Garver WS., Physiological and coordinate downregulation of the NPC1 and NPC2 genes are associated with the sequestration of LDL-derived cholesterol within endocytic compartments. J Cell Biochem 2009 108 1102 1116. doi: 10.1002/jcb.22339.
98. Ghosh S., Early steps in reverse cholesterol transport: cholesteryl ester hydrolase and other hydrolases. Curr Opin Endocrinol Diabetes Obes 2012 19 136 141. doi: 10.1097/MED.0b013e3283507836.
99. Ghosh S., Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Expert Rev Cardiovasc Ther 2011 9 329 340. doi: 10.1586/erc.11.16.
100. Neufeld EB, O'Brien K, Walts AD, Stonik JA, Malide D, Combs CA, Remaley AT., The human ABCG1 transporter mobilizes plasma membrane and late endosomal non-sphingomyelin-associated-cholesterol for efflux and esterification. Biology (Basel) 2014 3 866 891. doi: 10.3390/biology3040866.
101. Marcil M, Yu L, Krimbou L, Boucher B, Oram JF, Cohn JS, Genest J Jr., Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler Thromb Vasc Biol 1999 19 159 169
102. Ma L, Dong F, Zaid M, Kumar A, Zha X., ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation. J Biol Chem 2012 287 40502 40512. doi: 10.1074/jbc.M112.413245.
103. Liu Y, Tang C., Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 2012 1821 522 529. doi: 10.1016/j.bbalip.2011.08.015.
104. Yin K, Chen WJ, Zhou ZG, Zhao GJ, Lv YC, Ouyang XP, Yu XH, Fu Y, Jiang ZS, Tang CK., Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. J Atheroscler Thromb 2012 19 823 836
105. Dong F, Mo Z, Eid W, Courtney KC, Zha X., Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1. PLoS One 2014 9 e113789. doi: 10.1371/journal.pone.0113789.
106. Reboulleau A, Robert V, Vedie B, Doublet A, Grynberg A, Paul JL, Fournier N., Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis. J Mol Cell Cardiol 2012 53 196 205. doi: 10.1016/j.yjmcc.2012.05.015.
107. Nofer JR., Signal transduction by HDL: agonists, receptors, and signaling cascades. Handb Exp Pharmacol 2015 224 229 256. doi: 10.1007/978-3-319-09665-0-6.
108. Bocchetta S, Maillard P, Yamamoto M, Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection. PLoS One 2014 9 e92140. doi: 10.1371/journal.pone.0092140.
109. Sorci-Thomas MG, Thomas MJ., Why targeting HDL should work as a therapeutic tool, but has not. J Cardiovasc Pharmacol 2013 62 239 246. doi: 10.1097/FJC.0b013e31829d48a5.
110. Sorci-Thomas MG, Thomas MJ., The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 2002 12 121 128
111. Randolph GJ, Miller NE., Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest 2014 124 929 935. doi: 10.1172/JCI71610.
112. Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, Bharadwaj M, Walzem R, Chan L, Oka K, Thomas MJ, Sorci-Thomas MG., Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 2009 29 843 849. doi: 10.1161/ATVBAHA.108.183442.
113. Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, Bhat S, Gibbs DP Jr, Thomas MJ, Sorci-Thomas MG., Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/-mice. J Biol Chem 2010 285 36158 36169. doi: 10.1074/jbc.M110.134130.
114. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA., Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 2011 123 989 998. doi: 10.1161/CIRCULATIONAHA.110.984146.
115. Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, Thomas MJ, Sorci-Thomas MG, Randolph GJ., Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/-mice during disease regression. J Clin Invest 2011 121 2025 2036. doi: 10.1172/JCI43802.
116. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB., Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 2005 102 14729 14734. doi: 10.1073/pnas.0506233102.
117. van Gils JM, Derby MC, Fernandes LR, The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 2012 13 136 143. doi: 10.1038/ni.2205.
118. Moretti S, Procopio A, Lazzarini R, Rippo MR, Testa R, Marra M, Tamagnone L, Catalano A., Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 2008 111 2290 2299. doi: 10.1182/blood-2007-06-096529.
119. Salikhova A, Wang L, Lanahan AA, Liu M, Simons M, Leenders WP, Mukhopadhyay D, Horowitz A., Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res 2008 103 e71 e79. doi: 10.1161/CIRCRESAHA.108.183327.
120. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ., Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007 117 185 194. doi: 10.1172/JCI28549.
121. Robbins CS, Chudnovskiy A, Rauch PJ, Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012 125 364 374. doi: 10.1161/CIRCULATIONAHA.111.061986.
122. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ., Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007 117 195 205. doi: 10.1172/JCI29950.
123. Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen SH, Thomas MJ, Kreisel D, Swartz MA, Sorci-Thomas MG, Randolph GJ., Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 2013 123 1571 1579. doi: 10.1172/JCI63685.
124. Cuthbert JA, Lipsky PE., Provision of cholesterol to lymphocytes by high density and low density lipoproteins. Requirement for low density lipoprotein receptors. J Biol Chem 1987 262 7808 7818
125. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR., ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010 328 1689 1693. doi: 10.1126/science.1189731.
126. Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo CL, Wang M, Sanson M, Abramowicz S, Welch C, Bochem AE, Kuivenhoven JA, Yvan-Charvet L, Tall AR., ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 2011 121 4138 4149. doi: 10.1172/JCI57559.
127. Wang M, Subramanian M, Abramowicz S, Murphy AJ, Gonen A, Witztum J, Welch C, Tabas I, Westerterp M, Tall AR., Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arterioscler Thromb Vasc Biol 2014 34 976 984. doi: 10.1161/ATVBAHA.113.303097.
128. Swirski FK, Nahrendorf M., Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013 339 161 166. doi: 10.1126/science.1230719.
129. Weber GF, Chousterman BG, He S, Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 2015 347 1260 1265. doi: 10.1126/science.aaa4268.
130. Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, Mariani G, Laufer S, Sargiacomo M, Testa U., Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation. Br J Haematol 2009 145 399 411. doi: 10.1111/j.1365-2141.2009.07627.x.
131. Galkina E, Ley K., Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol 2009 27 165 197. doi: 10.1146/annurev.immunol.021908.132620.
132. Hansson GK, Holm J, Jonasson L., Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989 135 169 175
133. Armstrong AJ, Gebre AK, Parks JS, Hedrick CC., ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J Immunol 2010 184 173 183. doi: 10.4049/jimmunol.0902372.
134. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD, Tontonoz P., LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008 134 97 111. doi: 10.1016/j.cell.2008.04.052.
135. Xavier R, Brennan T, Li Q, McCormack C, Seed B., Membrane compartmentation is required for efficient T cell activation. Immunity 1998 8 723 732
136. Viola A., The amplification of TCR signaling by dynamic membrane microdomains. Trends Immunol 2001 22 322 327
137. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A., T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999 283 680 682
138. Nagafuku M, Okuyama K, Onimaru Y, Suzuki A, Odagiri Y, Yamashita T, Iwasaki K, Fujiwara M, Takayanagi M, Ohno I, Inokuchi J., CD4 and CD8 T cells require different membrane gangliosides for activation. Proc Natl Acad Sci USA 2012 109 E336 E342. doi: 10.1073/pnas.1114965109.
139. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T., Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 8 27. doi: 10.1111/j.0105-2896.2006.00427.x.
140. Nazarov-Stoica C, Surls J, Bona C, Casares S, Brumeanu TD., CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message. J Immunol 2009 182 102 110
141. Maganto-García E, Bu DX, Tarrio ML, Alcaide P, Newton G, Griffin GK, Croce KJ, Luscinskas FW, Lichtman AH, Grabie N., Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol 2011 187 3521 3529. doi: 10.4049/jimmunol.1003947.
142. Maganto-García E, Tarrio ML, Grabie N, Bu DX, Lichtman AH., Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 2011 124 185 195. doi: 10.1161/CIRCULATIONAHA.110.006411.
143. Gotsman I, Grabie N, Gupta R, Dacosta R, MacConmara M, Lederer J, Sukhova G, Witztum JL, Sharpe AH, Lichtman AH., Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006 114 2047 2055. doi: 10.1161/CIRCULATIONAHA.106.633263.
144. Bour-Jordan H, Bluestone JA., Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 2009 229 41 66. doi: 10.1111/j.1600-065X.2009.00775.x.
145. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK., Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003 112 1342 1350. doi: 10.1172/JCI18607.
146. Hansson GK, Libby P., The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 508 519. doi: 10.1038/nri1882.
147. Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H., mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013 499 485 490. doi: 10.1038/nature12297.
148. Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J, Borges CM, Townamchai N, Gerriets VA, Rathmell JC, Sharpe AH, Bluestone JA, Turka LA., Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat Immunol 2015 16 188 196. doi: 10.1038/ni.3077.
149. Jan M, Meng S, Chen NC, Mai J, Wang H, Yang XF., Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics. J Biomed Biotechnol 2010 2010 459798. doi: 10.1155/2010/459798.
150. Shaw PX, Goodyear CS, Chang MK, Witztum JL, Silverman GJ., The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 2003 170 6151 6157
151. Lichtman AH, Binder CJ, Tsimikas S, Witztum JL., Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 2013 123 27 36. doi: 10.1172/JCI63108.
152. Jury EC, Flores-Borja F, Kalsi HS, Lazarus M, Isenberg DA, Mauri C, Ehrenstein MR., Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur J Immunol 2010 40 569 578. doi: 10.1002/eji.200939781.
153. Wang W, Xu H, Shi Y, Nandedkar S, Zhang H, Gao H, Feroah T, Weihrauch D, Schulte ML, Jones DW, Jarzembowski J, Sorci-Thomas M, Pritchard KA Jr., Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J Lipid Res 2010 51 2560 2570. doi: 10.1194/jlr.M004549.
154. Zabalawi M, Bhat S, Loughlin T, Thomas MJ, Alexander E, Cline M, Bullock B, Willingham M, Sorci-Thomas MG., Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 2003 163 1201 1213. doi: 10.1016/S0002-9440(10)63480-3.
155. Tavori H, Su YR, Yancey PG, Giunzioni I, Wilhelm AJ, Blakemore JL, Zabalawi M, Linton MF, Sorci-Thomas MG, Fazio S., Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL. J Lipid Res 2015 56 635 643. doi: 10.1194/jlr.M056408.
156. Tiniakou I, Drakos E, Sinatkas V, Van Eck M, Zannis VI, Boumpas D, Verginis P, Kardassis D., High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function. J Immunol 2015 194 4676 4687. doi: 10.4049/jimmunol.1402870.